124 related articles for article (PubMed ID: 26782169)
1. Risk factors for mortality during antiretroviral therapy in older populations in resource-limited settings.
O'Brien D; Spelman T; Greig J; McMahon J; Ssonko C; Casas E; Mesic A; Du Cros P; Ford N
J Int AIDS Soc; 2016; 19(1):20665. PubMed ID: 26782169
[TBL] [Abstract][Full Text] [Related]
2. Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries.
Pujades-Rodríguez M; Balkan S; Arnould L; Brinkhof MA; Calmy A;
JAMA; 2010 Jul; 304(3):303-12. PubMed ID: 20639564
[TBL] [Abstract][Full Text] [Related]
3. Early mortality among children and adults in antiretroviral therapy programs in Southwest Ethiopia, 2003-15.
Gesesew HA; Ward P; Woldemichael K; Mwanri L
PLoS One; 2018; 13(6):e0198815. PubMed ID: 29912974
[TBL] [Abstract][Full Text] [Related]
4. Higher Risks of Virologic Failure and All-Cause Deaths Among Older People Living with HIV in Chongqing, China.
Wu G; Zhou C; Zhang X; Zhang W; Lu R; Ouyang L; Xing H; Shao Y; Ruan Y; Qian HZ
AIDS Res Hum Retroviruses; 2019; 35(11-12):1095-1102. PubMed ID: 31544479
[TBL] [Abstract][Full Text] [Related]
5. [Study on the mortality and risk factors among HIV/AIDS patients receiving antiretroviral therapy in Xinjiang Uygur Autonomous Region].
Ni M; Chen X; Hu X; Ma Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Nov; 48(11):953-8. PubMed ID: 25582364
[TBL] [Abstract][Full Text] [Related]
6. Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study.
Silverman RA; John-Stewart GC; Beck IA; Milne R; Kiptinness C; McGrath CJ; Richardson BA; Chohan B; Sakr SR; Frenkel LM; Chung MH
PLoS One; 2019; 14(10):e0223411. PubMed ID: 31584992
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for unstructured treatment interruptions and association with survival in low to middle income countries.
McMahon JH; Spelman T; Ford N; Greig J; Mesic A; Ssonko C; Casas EC; O'Brien DP
AIDS Res Ther; 2016; 13():25. PubMed ID: 27408611
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and outcomes of older HIV-infected patients receiving antiretroviral therapy in Malawi: A retrospective observation cohort study.
Tweya H; Feldacker C; Heller T; Gugsa S; Ng'ambi W; Nthala O; Kalulu M; Chiwoko J; Banda R; Makwinja A; Phiri S
PLoS One; 2017; 12(7):e0180232. PubMed ID: 28686636
[TBL] [Abstract][Full Text] [Related]
9. Improved survival in HIV treatment programmes in Asia.
De La Mata NL; Kumarasamy N; Khol V; Ng OT; Van Nguyen K; Merati TP; Pham TT; Lee MP; Durier N; Law M
Antivir Ther; 2016; 21(6):517-527. PubMed ID: 26961354
[TBL] [Abstract][Full Text] [Related]
10. Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users.
Spillane H; Nicholas S; Tang Z; Szumilin E; Balkan S; Pujades-Rodriguez M
Trop Med Int Health; 2012 Oct; 17(10):1255-63. PubMed ID: 22863110
[TBL] [Abstract][Full Text] [Related]
11. Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.
Carriquiry G; Fink V; Koethe JR; Giganti MJ; Jayathilake K; Blevins M; Cahn P; Grinsztejn B; Wolff M; Pape JW; Padgett D; Madero JS; Gotuzzo E; McGowan CC; Shepherd BE
J Int AIDS Soc; 2015; 18(1):20016. PubMed ID: 26165322
[TBL] [Abstract][Full Text] [Related]
12. Effect of age at initiation of antiretroviral therapy on treatment outcomes; A retrospective cohort study at a large HIV clinic in southwestern Uganda.
Ssebutinde P; Kyamwanga IT; Turyakira E; Asiimwe S; Bajunirwe F
PLoS One; 2018; 13(8):e0201898. PubMed ID: 30110364
[TBL] [Abstract][Full Text] [Related]
13. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
[TBL] [Abstract][Full Text] [Related]
14. Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults.
Mutevedzi PC; Lessells RJ; Rodger AJ; Newell ML
PLoS One; 2011; 6(7):e21795. PubMed ID: 21747959
[TBL] [Abstract][Full Text] [Related]
15. Incidence of WHO stage 3 and 4 conditions following initiation of anti-retroviral therapy in resource limited settings.
Curtis AJ; Marshall CS; Spelman T; Greig J; Elliot JH; Shanks L; Du Cros P; Casas EC; Da Fonseca MS; O'Brien DP
PLoS One; 2012; 7(12):e52019. PubMed ID: 23284857
[TBL] [Abstract][Full Text] [Related]
16. Pre-ART nutritional status and its association with mortality in adult patients enrolled on ART at Fiche Hospital in North Shoa, Oromia region, Ethiopia: a retrospective cohort study.
Tesfamariam K; Baraki N; Kedir H
BMC Res Notes; 2016 Dec; 9(1):512. PubMed ID: 27998310
[TBL] [Abstract][Full Text] [Related]
17. Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study.
Hermans SM; van Leth F; Manabe YC; Hoepelman AI; Lange JM; Kambugu A
HIV Med; 2012 Jul; 13(6):337-44. PubMed ID: 22296211
[TBL] [Abstract][Full Text] [Related]
18. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.
Kohli R; Lo Y; Howard AA; Buono D; Floris-Moore M; Klein RS; Schoenbaum EE
Clin Infect Dis; 2005 Sep; 41(6):864-72. PubMed ID: 16107987
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of antiretroviral therapy over a 10-year period of expansion: a multicohort analysis of African and Asian HIV programs.
Grimsrud A; Balkan S; Casas EC; Lujan J; Van Cutsem G; Poulet E; Myer L; Pujades-Rodriguez M
J Acquir Immune Defic Syndr; 2014 Oct; 67(2):e55-66. PubMed ID: 24977472
[TBL] [Abstract][Full Text] [Related]
20. Ten-year mortality trends among persons diagnosed with HIV infection in England and Wales in the era of antiretroviral therapy: AIDS remains a silent killer.
Simmons RD; Ciancio BC; Kall MM; Rice BD; Delpech VC
HIV Med; 2013 Nov; 14(10):596-604. PubMed ID: 23672663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
